Life Sciences

  • Microbiome / Nutrition / Foodtech / Lifestyle
  • Medtech / Connected health / Digital health
  • Biotech & pharmaceuticals
  • Industrial Biotech & Cleantech
  • Animal health / Animal Feed & Nutrition

Read more

Digital Technologies

  • Fintech
  • Retailtech
  • Other digital innovative solutions
  • Hardware & telecom

Read more

Sport & Performance Capital

  • Sport-Health
  • Equipment
  • Food-Nutrition
  • IOT-Digital
  • Sports practice

Read more

Blue Economy

  • Sustainable aquaculture
  • Nutrition Cosmetics Health
  • Industrial Products & Biomaterials
  • Biopolymers and biopackaging
  • Digitalization Blue 3.0
  • Recycling, Bioremediation
  • Climate & Carbon
  • Bioenergies, hydrogen

Read more

News

  • MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation
    23 March 2026

    MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation

    MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

  • Obesity: The Microbiome at the Intersection of Nutrition and Pharma
    4 March 2026

    Obesity: The Microbiome at the Intersection of Nutrition and Pharma

    In a groundbreaking report Microbiome & Obesity: A...

    Read more...
  • Zenniz Completes $6 Million Raise, Establishing USA HQ
    20 February 2026

    Zenniz Completes $6 Million Raise, Establishing USA HQ

    Zenniz, the world's leading provider of smart tennis...

  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    11 February 2026

    Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis

    Microbiotica, a clinical-stage biopharma company...

  • Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
    10 February 2026

    Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

    Kainova Therapeutics (“the Company”), a key player...